Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019

@T | Works | 9F6C41 | Creators 

A list of the users contributing to this article.

Ender
editor
By using this site, you agree to the Terms of Service and Privacy Policy. Idealogs® is a registered trademark of the Idealogical Foundation, Inc., a non-profit organization.
About
|
Contact
|
Docs
|
Developers
|
Donate
Idealogs Extension Icon